“United Therapeutics Files Patent Suit Against Liquidia Over Lung Disease Drug Tyvaso”

United Therapeutics Corp. has filed another patent infringement lawsuit in an attempt to prevent Liquidia Technologies Inc. from marketing its own version of Tyvaso, a widely used treatment for lung disease. The case has been brought before a federal court in North Carolina as United Therapeutics seeks to defend its intellectual property rights concerning this significant pharmaceutical product. For additional details on the legal dispute, read more here.